Physician profile
Paul Schwartz
NPI 1780796904
$124,273.25
in general payments reported to CMS, 2019-2025
18 companies · $28K in 2025
The $28K reported for 2025 was more than what 93% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $56K · 2020: $9,521 · 2021: $17K · 2022: $748 · 2023: $4,405 · 2024: $7,864 · 2025: $28K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $30K · Travel and Lodging: $8,017 · Food and Beverage: $1,947 · Gift: $74.42.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $30,217.59 |
| Travel and Lodging | $8,016.79 |
| Food and Beverage | $1,947.24 |
| Gift | $74.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $45,039.19 | 2019-2020 | |
| Shoulder Innovations, INC. | $31,388.64 | 2021-2025 | Inset System |
| Genesis Software Innovations, LLC | $19,053.92 | 2021-2025 | |
| Steelhead Surgical INC | $12,513.10 | 2019-2023 | |
| Integra Lifesciences Corporation | $10,963.71 | 2019-2020 | |
| Zimmer Biomet Holdings, INC. | $2,322.62 | 2020-2025 | Persona |
| Arthrex, INC. | $2,000.00 | 2020 | |
| Stryker Corporation | $449.70 | 2021 | |
| Catalyst Orthoscience | $95.23 | 2021 | |
| Ossio INC | $90.15 | 2023 | |
| Think Surgical, INC. | $83.47 | 2023 | |
| Ascension Orthopedics, INC. | $75.59 | 2019 | |
| Bioventus LLC | $59.51 | 2020-2022 | |
| Lima USA, INC. | $40.25 | 2020 | |
| Merck Sharp & Dohme LLC | $32.90 | 2024 | Bridion |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon US, LLC | $28.91 | 2025 | Dermabond Prineo, Stratafix, Ethicon |
| Vertex Pharmaceuticals Incorporated | $23.58 | 2025 | |
| Pacira Therapeutics, INC. | $12.78 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$289,385.06 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Schwartz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.